Aytu BioScience And Neos Therapeutics Earlier Announced Definitive Merger Agreement Valued At ~$44.9M; Neos Stockholders Will Be Entitled To Receive 0.1088 Shares Of Common Stock Of Aytu For Each Share Of Neos Common Stock Held